Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Disease Progression × pomalidomide × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 79 Recurrence 17 Neoplasms 7 Neoplasms, Plasma Cell 3 Lymphoma, Non-Hodgkin 3 Sarcoma, Kaposi 2 Leukemia, Myeloid, Acute 2 Immunoglobulin Light-chain Amyloidosis 2 Hematologic Neoplasms 2 Chromosome 17 deletion 2 Acquired Immunodeficiency Syndrome 2 Waldenstrom Macroglobulinemia 1 Smoldering Multiple Myeloma 1 Proteostasis Deficiencies 1 Plasmacytoma 1 Plasmablastic Lymphoma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multi-centric Castleman's Disease 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Hodgkin Disease 1 Epstein-Barr Virus Infections 1 Burkitt Lymphoma 1 Alzheimer Disease 1

Interventions

Cisplatin 3 capivasertib 2 Radiosurgery 2 Nivolumab 2 Carboplatin 2 tivozanib 1 pazopanib 1 niraparib 1 lutetium Lu 177 dotatate 1 fludarabine phosphate 1 fludarabine 1 encorafenib 1 durvalumab 1 copanlisib 1 cemiplimab 1 axicabtagene ciloleucel 1 avasopasem manganese 1 abexinostat 1 Receptors, Interleukin-6 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Pemetrexed 1 Paclitaxel 1 Oxaliplatin 1 Leucovorin 1 Interleukin 1 Receptor Antagonist Protein 1 Gemcitabine 1 Fulvestrant 1 Folfox protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡